Skyrizi

Made by

• AbbVie

Active Ingredient

Risankizumab (genetical recombination)

Prospectus

Approval date

2019/3/26

Treats

• Psoriasis
• Pustular psoriasis

Dosages

• Skyrizi - 243807円／筒